| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |